AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Cannabis Bioscience International Holdings, Inc.

$0 -$0.00 (-81.82%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0
Market Cap
1.16M
AVG Volume
16.98M
Trailing/Forward PE
-0/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
025M50M75M100M2008200920102018201920202021202220232024
CBIH Revenue (USD) by year
PeriodRevenue (USD)
2024303.02K
2023269.15K
2022315.62K
2021214.08K
2020505.68K
2019296.61K
201890.06K
201083.46M
200974M
200855.32M
Net Income (USD)
-20M-10M010M20M2008200920102018201920202021202220232024
CBIH Net Income (USD) by year
PeriodNet Income (USD)
2024-548.82K
2023-594.82K
2022-1.08M
2021-879.19K
2020-448.47K
2019-91.98K
20181.62K
201010.46M
2009-13.43M
20088.76M
Operating Income (USD)
-20M-10M010M20M2008200920102018201920202021202220232024
CBIH Operating Income (USD) by year
PeriodOperating Income (USD)
2024-381.26K
2023-404.57K
2022-1.04M
2021-894.2K
2020-445.37K
2019-111.98K
201811.06K
201014.31M
2009-13.29M
20089.48M
EBITDA (USD)
-20M-10M010M20M2008200920102018201920202021202220232024
CBIH EBITDA (USD) by year
PeriodEBITDA (USD)
2024-339.25K
2023-401.55K
2022-954.23K
2021-837.77K
2020-371.53K
2019-71.98K
201811.06K
201016.21M
2009-10.75M
20089.53M
Cash Flows (USD)
-15M-10M-5M05M2008200920102018201920202021202220232024
CBIH Cash Flows (USD) by year
PeriodCash Flows (USD)
2024-476.04K
2023-485.9K
2022-911.75K
2021-863.3K
2020-404.85K
2019-201.9K
20188.09K
2010-575.4K
2009-12.9M
20082.47M
EPS (USD)
-200002000400060002008200920102018201920202021202220232024
CBIH EPS (USD) by year
PeriodEPS (USD)
2024-0.05
2023-0.06
2022-0.12
2021-0.11
2020-0.06
2019-0
20180
2010807.85
2009-1633.17
20085900.05
Expenses (USD)
-10M010M20M30M40MSG&ACapex2008200920102018201920202021202220232024
CBIH Expenses (USD) by year
PeriodExpenses (USD)
2024528.58K
2023520.88K
20221.24M
20211.06M
2020951.04K
2019408.59K
201888.6K
201013.69M
200934.01M
20081.2M
Cash & Debt (USD)
0500K1M1.5MCashLong Term DebtShort Term Debt2007200820092010201920202021202220232024
CBIH Cash & Debt (USD) by year
PeriodCash & Debt (USD)
202412.95K
2023755
20228.91K
202131.68K
202041.32K
2019113.29K
2010136.7K
20091.1M
2008921.84K
200728.04K
Debt ratios
-0.4-0.200.20.42010201920202021202220232024
CBIH Debt ratios by year
PeriodDebt ratios
2024-0.16
2023-0.17
2022-0.17
2021-0.28
20200.01
20190.01
20100.24
Margins
0%25%50%75%100%2008200920102018201920202021202220232024
CBIH Margins by year
PeriodMargins
202486.76%
202345.51%
202265.48%
202178.16%
20200%
201929.05%
201822.86%
201032.44%
200924.38%
200819.32%
Return on Capital
-200%-100%0%100%200%300%2007200820092010201920202021202220232024
CBIH Return on Capital by year
PeriodReturn on Capital
202447.17%
202355.13%
2022182.79%
2021244.17%
2020172.08%
2019146.82%
201016.07%
2009-26.8%
200839.63%
2007-145.54%
Shares Outstanding
05M10M15M2008200920102018201920202021202220232024
CBIH Shares Outstanding by year
PeriodShares Outstanding
202410.72M
202310.37M
202210.03M
20218.43M
20207.85M
20198.68M
20184.67M
201012.97K
200910.52K
20081.47K
Book Value Per Share (USD)
-5000050001000015000200002007200820092010201920202021202220232024
CBIH Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
2024-0.11
2023-0.1
2022-0.06
2021-0.04
2020-0.03
2019-0.01
20105014.97
20094766.02
200815020.34
200785.23
Total Assets (USD)
025M50M75M100M2007200820092010201920202021202220232024
CBIH Total Assets (USD) by year
PeriodTotal Assets (USD)
202431.88K
202357.16K
202243.38K
2021112.68K
202050.42K
2019127.29K
201093.04M
200971.71M
200834.84M
200728.04K
Employee Count
01232025
CBIH Employee Count by year
PeriodEmployee Count
20252
Free Cash Flow Yield
-15000%-10000%-5000%0%med -6639.42%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CBIH Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-20.97%
Sep 26-20.97%
Sep 26-13.98%
Aug 26-20.97%
Aug 26-20.97%
Aug 26-10.48%
Aug 26-13.98%
Jul 26-13.98%
Jul 26-10.48%
Jul 26-10.48%
Jul 26-10.48%
Jul 26-6.99%
Jun 26-8.39%
Jun 26-6.99%
Jun 26-8.22%
Jun 26-5.24%
May 26-6.99%
May 26-6.99%
May 26-6.99%
May 26-6.99%
May 26-6.99%
Apr 26-5.99%
Apr 26-5.24%
Apr 26-9.73%
Apr 26-7.78%
Mar 26-9.73%
Mar 26-9.73%
Mar 26-8.65%
Mar 26-8.65%
Feb 26-9.73%
Feb 26-8.65%
Feb 26-11812.03%
Feb 26-11812.03%
Jan 26-11812.03%
Jan 26-9449.62%
Jan 26-8590.57%
Jan 26-6798.29%
Jan 26-8590.57%
Dec 25-6749.73%
Dec 25-9449.62%
Dec 25-6749.73%
Dec 25-9449.62%
Nov 25-9449.62%
Nov 25-11812.03%
Nov 25-9449.62%
Nov 25-9449.62%
Oct 25-9449.62%
Oct 25-9449.62%
Oct 25-8884.42%
Oct 25-8884.42%
Oct 25-8884.42%
Sep 25-8884.42%
Sep 25-8524.38%
Sep 25-8524.38%
Sep 25-8524.38%
Aug 25-7306.61%
Aug 25-10229.25%
Aug 25-10229.25%
Aug 25-9299.32%
Aug 25-10229.25%
Jul 25-8524.38%
Jul 25-11365.84%
Jul 25-10229.25%
Jul 25-10229.25%
Jun 25-8524.38%
Jun 25-7991.6%
Jun 25-10229.25%
Jun 25-8524.38%
May 25-8524.38%
May 25-10229.25%
May 25-8524.38%
May 25-7306.61%
May 25-7868.66%
Apr 25-8524.38%
Apr 25-4699.55%
Apr 25-4699.55%
Apr 25-3818.39%
Mar 25-4699.55%
Mar 25-3818.39%
Mar 25-4363.87%
Mar 25-3818.39%
Feb 25-4072.95%
Feb 25-4072.95%
Feb 25-4363.87%
Feb 25-3818.39%
Jan 25-4699.55%
Jan 25-4699.55%
Jan 25-6639.42%
Jan 25-6639.42%
Jan 25-6639.42%
Dec 24-6128.69%
Dec 24-6639.42%
Dec 24-6639.42%
Dec 24-6639.42%
Nov 24-7243%
Nov 24-7807.52%
Nov 24-7206.95%
Nov 24-7495.22%
Nov 24-7206.95%
Oct 24-7807.52%
Price to Sales
0204060med 0.02Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CBIH Price to Sales by year
PeriodPrice to Sales
Sep 269.4
Sep 269.4
Sep 2614.11
Aug 269.4
Aug 269.4
Aug 2618.81
Aug 2614.11
Jul 2614.11
Jul 2618.81
Jul 2618.81
Jul 2618.81
Jul 2628.21
Jun 2623.51
Jun 2628.21
Jun 2623.98
Jun 2637.62
May 2628.21
May 2628.21
May 2628.21
May 2628.21
May 2628.21
Apr 2632.92
Apr 2637.62
Apr 2636.52
Apr 2645.65
Mar 2636.52
Mar 2636.52
Mar 2641.08
Mar 2641.08
Feb 2636.52
Feb 2641.08
Feb 260.03
Feb 260.03
Jan 260.03
Jan 260.04
Jan 260.04
Jan 260.05
Jan 260.04
Dec 250.05
Dec 250.04
Dec 250.05
Dec 250.04
Nov 250.04
Nov 250.03
Nov 250.04
Nov 250.04
Oct 250.04
Oct 250.04
Oct 250.02
Oct 250.02
Oct 250.02
Sep 250.02
Sep 250.02
Sep 250.02
Sep 250.02
Aug 250.02
Aug 250.02
Aug 250.02
Aug 250.02
Aug 250.02
Jul 250.02
Jul 250.01
Jul 250.02
Jul 250.02
Jun 250.02
Jun 250.02
Jun 250.02
Jun 250.02
May 250.02
May 250.02
May 250.02
May 250.02
May 250.02
Apr 250.02
Apr 250.02
Apr 250.02
Apr 250.02
Mar 250.02
Mar 250.02
Mar 250.02
Mar 250.02
Feb 250.02
Feb 250.02
Feb 250.02
Feb 250.02
Jan 250.02
Jan 250.02
Jan 250.02
Jan 250.02
Jan 250.02
Dec 240.02
Dec 240.02
Dec 240.02
Dec 240.02
Nov 240.02
Nov 240.02
Nov 240.03
Nov 240.02
Nov 240.03
Oct 240.02
Cannabis Bioscience International Holdings, Inc.
CBIH
Stockpicker

Video analysis: CBIH

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: CBIH

CBIH Announces Recognition Initiative Funded Through CEO's Personal Share Holdings

feeds.newsfilecorp.com · 6 Jul 2026

CBIH Announces Recognition Initiative Funded Through CEO's Personal Share Holdings

Houston, Texas--(Newsfile Corp. - July 6, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on

Cannabis Bioscience International Holdings Opens New Revenue Pathway with First VitaCookies Licensing Agreement

newsfilecorp.com · 22 Jun 2026

Cannabis Bioscience International Holdings Opens New Revenue Pathway with First VitaCookies Licensing Agreement

Houston, Texas--(Newsfile Corp. - June 22, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today announced the beginning of a new commercial chapter for VitaCookies with the signing of its first licensing agreement. This milestone moves VitaCookies from internal development toward commercial execution, positioning the brand as a structured growth opportunity built on CBIH's formulations, operational know-how, quality standards, and wellness-oriented vision.

CBIH Announces Patent-Related Scientific Framework for PTSD-Focused Cannabinoid and Psilocybin Research

newsfilecorp.com · 15 Jun 2026

CBIH Announces Patent-Related Scientific Framework for PTSD-Focused Cannabinoid and Psilocybin Research

Houston, Texas--(Newsfile Corp. - June 15, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading under the ticker symbol CBIH, today announced a new chapter in its PTSD-focused research journey, marked by the completion of its patent-related work and the continued exploration of the scientific relationship between cannabinoids and psilocybin in relation to trauma, memory, emotional regulation, and recovery. PTSD affects veterans, first responders, survivors of sexual assault and domestic violence, children exposed to trauma, families, and communities.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.